Fried, LP, Tangen, CM, Walston, J, Newman, AB, Hirsch, C, Gottdiener, J, et al. Frailty in older adults evidence for a phenotype. Journals of Gerontology Series A, Biological Sciences and Medical Sciences. 2001;56(3):146–57.Google Scholar

Morley, JE, Vellas, B, van Kan, GA, Anker, SD, Bauer, JM, Bernabei, R, et al. Frailty consensus: a call to action. Journal of the American Medical Directors Association. 2013;14(6):392–7.Google Scholar

Song, X, Mitnitski, A, Prevalence, Rockwood K. and 10-year outcomes of frailty in older adults in relation to deficit accumulation. Journal of the American Geriatrics Society. 2010;58(4):681–7.Google Scholar

Chen, X, Mao, G, Leng, SX. Frailty syndrome: an overview. Clinical Interventions in Aging. 2014;9:433–41.Google Scholar

Rockwood, K, Andrew, M, Mitnitski, A. A comparison of two approaches to measuring frailty in elderly people. Journals of Gerontology Series A, Biological Sciences and Medical Sciences. 2007;62(7):738–43.Google Scholar

Rodriguez-Manas, L, Feart, C, Mann, G, Vina, J, Chatterji, S, Chodzko-Zajko, W, et al. Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference project. Journals of Gerontology Series A, Biological Sciences and Medical Sciences. 2013;68(1):62–7.Google Scholar

Bandeen-Roche, K, Xue, QL, Ferrucci, L, Walston, J, Guralnik, JM, Chaves, P, et al. Phenotype of frailty: characterization in the women’s health and aging studies. Journals of Gerontology Series A, Biological Sciences and Medical Sciences. 2006;61(3):262–6.Google Scholar

Xue, QL. The frailty syndrome: definition and natural history. Clinics in Geriatric Medicine. 2011;27(1):1–15.CrossRefGoogle ScholarPubMed

Theou, O, Brothers, TD, Mitnitski, A, Rockwood, K. Operationalization of frailty using eight commonly used scales and comparison of their ability to predict all-cause mortality. Journal of the American Geriatrics Society. 2013;61(9):1537–51.Google Scholar

Bouillon, K, Kivimaki, M, Hamer, M, Sabia, S, Fransson, EI, Singh-Manoux, A, et al. Measures of frailty in population-based studies: an overview. BMC Geriatrics. 2013;13:64.Google Scholar

Abellan van Kan, G, Rolland, Y, Houles, M, Gillette-Guyonnet, S, Soto, M, Vellas, B. The assessment of frailty in older adults. Clinics in Geriatric Medicine. 2010;26(2):275–86.Google Scholar

Malmstrom, TK, Miller, DK, Morley, JE. A comparison of four frailty models. Journal of the American Geriatrics Society. 2014;62(4):721–6.Google Scholar

Shamliyan, T, Talley, KM, Ramakrishnan, R, Kane, RL. Association of frailty with survival: a systematic literature review. Ageing Research Reviews. 2013;12(2):719–36.Google Scholar

Cigolle, CT, Ofstedal, MB, Tian, Z, Blaum, CS. Comparing models of frailty: the Health and Retirement Study. Journal of the American Geriatrics Society. 2009;57(5):830–9.Google Scholar

Bowles, J, Brooks, T, Hayes-Reams, P, Butts, T, Myers, H, Allen, W, et al. Frailty, family, and church support among urban African American elderly. Journal of Health Care for the Poor and Underserved. 2000;11(1):87–99.Google Scholar

Ottenbacher, KJ, Ostir, GV, Peek, MK, Snih, SA, Raji, MA, Markides, KS. Frailty in older Mexican Americans. Journal of the American Geriatrics Society. 2005;53(9):1524–31.Google Scholar

Gill, TM, Gahbauer, EA, Han, L, Allore, HG. Trajectories of disability in the last year of life. New England Journal of Medicine. 2010;362(13):1173–80.CrossRefGoogle ScholarPubMed

Robertson, DA, Savva, GM, Kenny, RA. Frailty and cognitive impairment–a review of the evidence and causal mechanisms. Ageing Research Reviews. 2013;12(4):840–51.Google Scholar

Afilalo, J, Alexander, KP, Mack, MJ, Maurer, MS, Green, P, Allen, LA, et al. Frailty assessment in the cardiovascular care of older adults. Journal of the American College of Cardiology. 2014;63(8):747–62.Google Scholar

Xue, QL, Bandeen-Roche, K, Varadhan, R, Zhou, J, Fried, LP. Initial manifestations of frailty criteria and the development of frailty phenotype in the Women’s Health and Aging Study II. Journals of Gerontology Series A, Biological Sciences and Medical Sciences. 2008;63(9):984–90.Google Scholar

Gill, TM, Gahbauer, EA, Allore, HG, Han, L. Transitions between frailty states among community-living older persons. Archives of Internal Medicine. 2006;166(4):418–23.Google Scholar

Leng, S, Chaves, P, Koenig, K, Walston, J. Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. Journal of the American Geriatrics Society. 2002;50(7):1268–71.CrossRefGoogle ScholarPubMed

Mohler, MJ, Fain, MJ, Wertheimer, AM, Najafi, B, Nikolich-Žugich, J. The Frailty Syndrome: Clinical measurements and basic underpinnings in humans and animals. Experimental Gerontology. 2014;54:6–13.CrossRefGoogle ScholarPubMed

Ershler, WB, Keller, ET. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annual Review of Medicine. 2000;51:245–70.Google Scholar

Leng, SX, Xue, QL, Tian, J, Huang, Y, Yeh, SH, Fried, LP. Associations of neutrophil and monocyte counts with frailty in community-dwelling disabled older women: results from the Women’s Health and Aging Studies I. Experimental Gerontology. 2009;44(8):511–6.Google Scholar

Leng, SX, Cappola, AR, Andersen, RE, Blackman, MR, Koenig, K, Blair, M, et al. Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty. Aging Clinical and Experimental Research. 2004;16(2):153–7.Google Scholar

Travison, TG, Nguyen, AH, Naganathan, V, Stanaway, FF, Blyth, FM, Cumming, RG, et al. Changes in reproductive hormone concentrations predict the prevalence and progression of the frailty syndrome in older men: the concord health and ageing in men project. Journal of Clinical Endocrinology and Metabolism. 2011;96(8):2464–74.Google Scholar

Poehlman, ET, Toth, MJ, Fishman, PS, Vaitkevicius, P, Gottlieb, SS, Fisher, ML, et al. Sarcopenia in aging humans: the impact of menopause and disease. Journals of Gerontology Series A, Biological Sciences and Medical Sciences. 1995;50(Spec No):73–7.Google Scholar

Clegg, A, Young, J, Iliffe, S, Rikkert, MO, Rockwood, K. Frailty in elderly people. Lancet. 2013;381(9868):752–62.Google Scholar

Varadhan, R, Walston, J, Cappola, AR, Carlson, MC, Wand, GS, Fried, LP. Higher levels and blunted diurnal variation of cortisol in frail older women. Journals of Gerontology Series A, Biological Sciences and Medical Sciences. 2008;63(2):190–5.Google Scholar

Ko, FC. The clinical care of frail, older adults. Clinics in Geriatric Medicine. 2011;27(1):89–100.Google Scholar

Cruz-Jentoft, AJ, Baeyens, JP, Bauer, JM, Boirie, Y, Cederholm, T, Landi, F, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age and Ageing. 2010;39(4):412–23.CrossRefGoogle ScholarPubMed

Makary, MA, Segev, DL, Pronovost, PJ, Syin, D, Bandeen-Roche, K, Patel, P, et al. Frailty as a predictor of surgical outcomes in older patients. Journal of the American College of Surgeons. 2010;210(6):901–8.Google Scholar

Yao, X, Hamilton, RG, Weng, NP, Xue, QL, Bream, JH, Li, H, et al. Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults. Vaccine. 2011;29(31):5015–21.CrossRefGoogle ScholarPubMed

Ridda, I, Macintyre, CR, Lindley, R, Gao, Z, Sullivan, JS, Yuan, FF, et al. Immunological responses to pneumococcal vaccine in frail older people. Vaccine. 2009;27(10):1628–36.Google Scholar

Studenski, SA, Peters, KW, Alley, DE, Cawthon, PM, McLean, RR, Harris, TB, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. Journals of Gerontology Series A, Biological Sciences and Medical Sciences. 2014;69(5):547–58.Google Scholar

Bales, CW, Ritchie, CS. Sarcopenia, weight loss, and nutritional frailty in the elderly. Annual Review of Nutrition. 2002;22:309–23.Google Scholar

White, JV, Guenter, P, Jensen, G, Malone, A, Schofield, M. Consensus statement of the Academy of Nutrition and Dietetics/American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition). Journal of the Academy of Nutrition and Dietetics. 2012;112(5):730–8.Google Scholar

Weening-Dijksterhuis, E, de Greef, MH, Scherder, EJ, Slaets, JP, van der Schans, CP. Frail institutionalized older persons: A comprehensive review on physical exercise, physical fitness, activities of daily living, and quality-of-life. American Journal of Physical Medicine & Rehabilitation / Association of Academic Physiatrists. 2011;90(2):156–68.Google Scholar

Theou, O, Stathokostas, L, Roland, KP, Jakobi, JM, Patterson, C, Vandervoort, AA, et al. The effectiveness of exercise interventions for the management of frailty: a systematic review. Journal of Aging Research. 2011;2011:569194.Google Scholar

De Vries, NM, van Ravensberg, CD, Hobbelen, JS, Olde Rikkert, MG, Staal, JB, Nijhuis-van der Sanden, MW. Effects of physical exercise therapy on mobility, physical functioning, physical activity and quality of life in community-dwelling older adults with impaired mobility, physical disability and/or multi-morbidity: a meta-analysis. Ageing Research Reviews. 2012;11(1):136–49.Google Scholar

Peterson, MJ, Giuliani, C, Morey, MC, Pieper, CF, Evenson, KR, Mercer, V, et al. Physical activity as a preventative factor for frailty: the health, aging, and body composition study. Journals of Gerontology Series A, Biological Sciences and Medical Sciences. 2009;64(1):61–8.Google Scholar

Gill, TM, Baker, DI, Gottschalk, M, Peduzzi, PN, Allore, H, Byers, A. A program to prevent functional decline in physically frail, elderly persons who live at home. New England Journal of Medicine. 2002;347(14):1068–74.CrossRefGoogle ScholarPubMed

Milne, AC, Potter, J, Vivanti, A, Avenell, A. Protein and energy supplementation in elderly people at risk from malnutrition. Cochrane Database of Systematic Reviews. 2009;2:CD003288.Google Scholar

Cawood, AL, Elia, M, Stratton, RJ. Systematic review and meta-analysis of the effects of high protein oral nutritional supplements. Ageing Research Reviews. 2012;11(2):278–96.Google Scholar

Morley, JE. Should frailty be treated with testosterone? Aging Male: the Official Journal of the International Society for the Study of the Aging Male. 2011;14(1):1–3.Google Scholar

Muir, SW, Montero-Odasso, M. Effect of vitamin D supplementation on muscle strength, gait and balance in older adults: a systematic review and meta-analysis. Journal of the American Geriatrics Society. 2011;59(12):2291–300.Google Scholar

Wong, YY, McCaul, KA, Yeap, BB, Hankey, GJ, Flicker, L. Low vitamin D status is an independent predictor of increased frailty and all-cause mortality in older men: the Health in Men Study. Journal of Clinical Endocrinology and Metabolism. 2013;98(9):3821–8.Google Scholar

Lamberts, SW. The somatopause: to treat or not to treat? Hormone Research. 2000;53(Suppl 3):42–3.Google ScholarPubMed

Gallagher, P, Ryan, C, Byrne, S, Kennedy, J, O’Mahony, D. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. International Journal of Clinical Pharmacology and Therapeutics. 2008;46(2):72–83.Google Scholar

Onder, G, Penninx, BW, Balkrishnan, R, Fried, LP, Chaves, PH, Williamson, J, et al. Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet. 2002;359(9310):926–30.Google Scholar

Ellis, G, Whitehead, MA, Robinson, D, O’Neill, D, Langhorne, P. Comprehensive geriatric assessment for older adults admitted to hospital: meta-analysis of randomised controlled trials. BMJ (Clinical research ed). 2011;343:d6553.Google Scholar

Kawryshanker, S, Raymond, W, Ingram, K. Effect of frailty on functional gain, resource utilisation, and discharge destination: an observational prospective study in a GEM ward. Current Gerontology and Geriatric Research. 2014;2014:357857.Google Scholar

Villareal, DT, Chode, S, Parimi, N, Sinacore, DR, et al. Weight loss, exercise, or both and physical function in obese older adults. N Engl J Med. 2011;364:1218–29.CrossRefGoogle ScholarPubMed

Janssen, I, Shepard, DS, Katzmarzyk, PT, Roubenoff, R. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2004;52(1):80–5.CrossRefGoogle ScholarPubMed

Kim, SW. Multidimensional frailty score for the prediction of post-operative mortality risk. JAMA Surgery. 2014;149(7):633–40.Google Scholar

Joseph, B, Pandit, V, Zangbar, B, Kulvatunyou, N, Hashmi, A, et al. Superiority of frailty over age in predicting outcomes among geriatric trauma patients. JAMA Surg. 2014;149(8):766–72.Google Scholar

Lord, S, Sherrington, C, Menz, H, et al. Falls in Older People: Risk Factors and Strategies for Prevention. Cambridge: Cambridge University Press; 2007.Google Scholar

Close, J, Ellis, M, Hooper, R, et al. Prevention of falls in the elderly trial (PROFET): a randomised controlled trial. Lancet 1999;353:93–7.Google Scholar

Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. Web -based Injury Statistics Query and Reporting System (WISQARS) [online]. Accessed September 2, 2014.Google Scholar

Campbell, AJ, Borrie, MJ, Spears, GF, et al. Circumstances and consequences of falls experienced by a community population 70 years and over during a prospective study. Age Ageing 1990;19:136–41.CrossRefGoogle ScholarPubMed

Berg, WP, Alessio, HM, Mills, EM, et al. Circumstances and consequences of falls in independent community-dwelling older adults. Age Ageing 1997;26:261–8.CrossRefGoogle ScholarPubMed

Cali, CM, Kiel, DP. An epidemiologic study of fall-related fractures among institutionalized older people. JAGS 1995;43:1336–40.Google Scholar

Lord, SR, Ward, JA, Williams, P, et al. An epidemiological study of falls in older community-dwelling women: the Randwick falls and fractures study. Aust J Public Health 1993;17:240–5.Google Scholar

Ganz, DA, Bao, Y, Shekelle, PG, et al. Will my patient fall? JAMA 2007;297:77–86.Google Scholar

Brault, MW, Hootman, J, Helmick, CG, et al. Prevalence and most common causes of disability among adults, United States, 2005. MMWR 2009;58:421–6.Google Scholar

Verghese, J, LeValley, A, Hall, CB, et al. Epidemiology of gait disorders in community-residing older adults. J Am Geriatr Soc 2006;54:255–61.CrossRefGoogle ScholarPubMed

Salzman, B. Gait and balance disorders in older adults. Am Fam Physician 2010;82:61–8.Google Scholar

Waite, LM, Grayson, DA, Piguet, O, et al. Gait slowing as a predictor of incident dementia: 6-year longitudinal data from the Sydney Older Persons Study. J Neurol Sci 2005;229–230:89–93.Google Scholar

Bloem, BR, Haan, J, Lagaay, AM, et al. Investigation of gait in elderly subjects over 88 years of age. J Geriatr Psychiatry Neurol 1992;5:78–84.Google Scholar

Verghese, J, Lipton, RB, Hall, CB, et al. Abnormality of gait as a predictor of non-Alzheimer’s dementia. N Engl J Med 2002;347:1761–8.Google Scholar

Ashburn, A, Stack, E, Pickering, RM, et al. A community-dwelling sample of people with Parkinson’s disease: characteristics of fallers and non-fallers. Age Ageing 2001;30:47–52.Google Scholar

Burns, R. Falling and getting up again. Parkinson Report 1994;XV:18.Google Scholar

Koller, WC, Glatt, S, Vetere-Overfield, B, et al. Falls and Parkinson’s disease. Clin Neuropharmacol 1989;12:98–105.Google ScholarPubMed

Paulson, GW, Schaefer, K, Hallum, B. Avoiding mental changes and falls in older Parkinsons’ patients. Geriatrics 1986;41:59–62.Google Scholar

Paul, SS, Sherrington, C, Canning, CG, et al. The relative contribution of physical and cognitive fall risk factors in people with Parkinson’s disease: a large prospective cohort study. Neurorehabil Neural Repair 2014;28:282–90.Google Scholar

Salgado, R, Lord, SR, Packer, J, et al. Factors associated with falling in elderly hospital patients. Gerontology 1994;40:325–31.Google Scholar

O’Loughlin, JL, Robitaille, Y, Boivin, JF, et al. Incidence of and risk factors for falls and injurious falls among the community-dwelling elderly. Am J Epidemiol 1993;137:342–54.Google Scholar

Herndon, JG, Helmick, CG, Sattin, RW, et al. Chronic medical conditions and risk of fall injury events at home in older adults. JAGS 1997;45:739–43.Google Scholar

Dolinis, J, Harrison, JE. Factors associated with falling in older Adelaide residents. Aust N Z J Public Health 1997;21:462–8.Google Scholar

Campbell, AJ, Borrie, MJ, Spears, GF. Risk factors for falls in a community-based prospective study of people 70 years and older. J Gerontol 1989;44:M112–7.Google Scholar

Nevitt, MC, Cummings, SR, Kidd, S, et al. Risk factors for recurrent nonsyncopal falls: a prospective study. JAMA 1989;261:2663–8.CrossRefGoogle ScholarPubMed

Prudham, D, Evans, JG. Factors associated with falls in the elderly: a community study. Age Ageing 1981;10:141–6.Google Scholar

Hyndman, D, Ashburn, A, Stack, E. Fall events among people with stroke living in the community: Circumstances of falls and characteristics of fallers. Arch Phys Med Rehabil 2002;83:165–70.CrossRefGoogle ScholarPubMed

Mitoma, H, Hayashi, R, Yanagisawa, N, et al. Gait disturbances in patients with pontine medial tegmental lesions: clinical characteristics and gait analysis. Arch Neurol 2000;57:1048–57.Google Scholar

Moseley, A, Wales, A, Herbert, R, et al. Observation and analysis of hemiplegic gait: stance phase. Aust J Physiother 1993;39:259–67.Google Scholar

Moore, S, Schurr, K, Wales, A, et al. Observation and analysis of hemiplegic gait: swing phase. Aust J Physiother 1993;39:271–8.Google Scholar

Pijnappels, M, Bobbert, MF, van Dieen, JH. Contribution of the support limb in control of angular momentum after tripping. J Biomech 2004;37:1811–18.Google Scholar

Taylor, ME, Delbaere, K, Mikolaizak, AS, et al. Gait parameter risk factors for falls under simple and dual task conditions in cognitively impaired older people. Gait Posture 2013;37:126–30.Google Scholar

Verghese, J, Robbins, M, Holtzer, R, et al. Gait dysfunction in mild cognitive impairment syndromes. JAGS 2008;56:1244–51.Google Scholar

Montero-Odasso, M, Verghese, J, Beauchet, O, et al. Gait and cognition: a complementary approach to understanding brain function and the risk of falling. JAGS 2012;60:2127–36.Google Scholar

Herman, T, Mirelman, A, Giladi, N, et al. Executive control deficits as a prodrome to falls in healthy older adults: a prospective study linking thinking, walking, and falling. J Gerontol 2010;65:1086–92.Google Scholar

Holtzer, R, Friedman, R, Lipton, RB, et al. The relationship between specific cognitive functions and falls in aging. Neuropsychology 2007;21:540–8.Google Scholar

Tinetti, ME, Speechley, M, Ginter, SF. Risk factors for falls among elderly persons living in the community. N Engl J Med 1988;319:1701–7.Google Scholar

Morris, JC, Rubin, EH, Morris, EJ, et al. Senile dementia of the Alzheimer’s type: an important risk factor for serious falls. J Gerontol 1987;42:412–17.Google Scholar

Laird, RD, Studenski, S, Perera, S, et al. Fall history is an independent predictor of adverse health outcomes and utilization in the elderly. Am J Manag Care 2001;7:1133–8.Google Scholar

Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation–United States, 2010–2012. MMWR 2013;62:869–73.Google Scholar

Baan, H, Dubbeldam, R, Nene, AV, et al. Gait analysis of the lower limb in patients with rheumatoid arthritis: a systematic review. Semin Arthritis Rheum 2012;41:768–88 e8.Google Scholar

Broström, EW, Esbjörnsson, A-C, von Heideken, J, et al. Gait deviations in individuals with inflammatory joint diseases and osteoarthritis and the usage of three-dimensional gait analysis. Best Pract Res Clin Rheumatol 2012;26:409–22.Google Scholar

Blake, A, Morgan, K, Bendall, M, et al. Falls by elderly people at home – prevalence and associated factors. Age Ageing 1988;17:365–72.Google Scholar

Buchner, DM, Larson, EB. Falls and fractures in patients with Alzheimer-type dementia. JAMA 1987;257:1492–5.Google Scholar

Robbins, AS, Rubenstein, LZ, Josephson, KR, et al. Predictors of falls among elderly people – results of two population-based studies. Arch Int Med 1989;149:1628–33.Google Scholar

Tinetti, ME, Williams, TF, Mayewski, R. Fall risk index for elderly patients based on number of chronic disabilities Am J Med 1986;80:429–34.Google Scholar

Torgerson, DJ, Garton, MJ, Reid, DM. Falling and perimenopausal women. Age Ageing 1993;22:59–64.Google Scholar

Barbour, KE, Stevens, JA, Helmick, CG, et al. Falls and fall injuries among adults with arthritis – United States, 2012. MMWR 2014;63:379–83.Google Scholar

Gabell, A, Simons, MA, Nayak, USL. Falls in the healthy elderly: predisposing causes. Ergonomics 1985;28:965–75.Google Scholar

Thomas, MJ, Roddy, E, Zhang, W, et al. The population prevalence of foot and ankle pain in middle and old age: a systematic review. Pain 2011;152:2870–80.Google Scholar

Hung, L, Ho, Y, Leung, P. Survey of foot deformities among 166 geriatric inpatients. Foot Ankle 1985;5:156–64.Google Scholar

Helfand, AE, Cooke, HL, Walinsky, MD, et al. Foot problems associated with older patients – a focused podogeriatric study. J Am Podiatr Med Assoc 1998;88:237–41.Google Scholar

Black, JR, Hale, WE. Prevalence of foot complaints in the elderly. J Am Podiatr Med Assoc 1987;77:308–11.Google Scholar

Guralnik, J, Simonsick, E, Ferrucci, L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994;49:M85–94.Google Scholar

Benvenuti, F, Ferrucci, L, Guralnik, JM, et al. Foot pain and disability in older persons: an epidemiologic survey. JAGS 1995;43:479–84.Google Scholar

Menz, HB, Lord, SR. Gait instability in older people with hallux valgus. Foot Ankle Int 2005;26:483–9.CrossRefGoogle ScholarPubMed

Menz, HB, Morris, ME, Lord, SR. Foot and ankle risk factors for falls in older people: a prospective study. J Gerontol 2006;61:866–70.Google Scholar

Mickle, KJ, Munro, BJ, Lord, SR, et al. Foot pain, plantar pressures, and falls in older people: a prospective study. JAGS 2010;58:1936–40.Google Scholar

Tinetti, ME. Performance-oriented assessment of mobility problems in elderly patients. JAGS 1986;34:119–26.Google Scholar

Winter, DA. The Biomechanics and Motor Control of Human Gait: Normal, Elderly and Pathological. Waterloo, Ontario: University of Waterloo Press; 1991.Google Scholar

Kemoun, G, Thoumie, P, Boisson, D, et al. Ankle dorsiflexion delay can predict falls in the elderly. J Rehabil Med 2002;34:278–83.Google Scholar

Al-Yahya, E, Dawes, H, Smith, L, et al. Cognitive motor interference while walking: a systematic review and meta-analysis. Neurosci Biobehav Rev 2011;35:715–28.CrossRefGoogle ScholarPubMed

Owings, TM, Grabiner, MD. Variability of step kinematics in young and older adults. Gait Posture 2004;20:26–9.Google Scholar

Hausdorff, J, Rios, D, Edelberg, H. Gait variability and fall risk in community-living older adults: a 1-year prospective study. Arch Phys Med Rehabi 2001;82:1050–6.CrossRefGoogle ScholarPubMed

Di Fabio, RP, Kurszewski, WM, Jorgenson, EE, et al. Footlift asymmetry during obstacle avoidance in high-risk elderly. JAGS 2004;52:2088–93.Google Scholar

Verghese, J, Holtzer, R, Lipton, RB, et al. Quantitative gait markers and incident fall risk in older adults. J Gerontol 2009;64:896–901.Google Scholar

Abellan van Kan, G, Rolland, Y, Andrieu, S, et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging 2009;13:881–9.Google Scholar

Hardy, SE, Perera, S, Roumani, YF, et al. Improvement in usual gait speed predicts better survival in older adults. JAGS 2007;55:1727–34.Google Scholar

Studenski, S, Perera, S, Patel, K, et al. Gait speed and survival in older adults. JAMA 2011;305:50–8.Google Scholar

Murray, MP, Kory, RC, Clarkson, BH. Walking patterns in healthy old men. J Gerontol 1969;24:169–78.Google Scholar

Crowinshield, RD, Brand, RA, Johnston, RC. The effects of walking velocity and age on hip kinematics and kinetics. Clin Orthop Rel Res 1978;132:140–4.Google Scholar

Elble, RJ, Thomas, SS, Higgins, C, et al. Stride-dependent changes in gait of older people. J Neurol 1991;238:1–5.Google Scholar

Kerrigan, DC, Todd, MK, Croce, UD, et al. Biomechanical gait alterations independent of speed in the healthy elderly: evidence for specific limiting impairments. Arch Phys Med Rehabil 1998;79:317–22.Google Scholar

Hageman, PA, Blanke, DJ. Comparison of gait of young women and elderly women. Phys Ther 1986;66:1382–7.Google Scholar

Winter, DA, Patla, AE, Frank, JS, et al. Biomechanical walking pattern changes in the fit and healthy elderly. Phys Ther 1990;70:340–7.Google Scholar

Judge, JO, Davis, RB, 3rd, Ounpuu, S. Step length reductions in advanced age: the role of ankle and hip kinetics. J Gerontol 1996;51:M303–12.Google Scholar

McGibbon, C, Krebs, D. Age-related changes in lower trunk coordination and energy transfer during gait. J Neurophysiol 2001;85:1923–31.Google Scholar

McGibbon, C, Puniello, M, Krebs, D. Mechanical energy transfer during gait in relation to strength impairment and pathology in elderly women. Clin Biomech 2001;16:324–33.Google Scholar

McGibbon, CA, Krebs, DE, Puniello, MS. Mechanical energy analysis identifies compensatory strategies in disabled elders’ gait. J Biomech 2001;34:481–90.Google Scholar

Mills, PM, Barrett, RS. Swing phase mechanics of healthy young and elderly men. Hum Mov Sci 2001;20:427–46.Google Scholar

Murray, MP, Drought, AB, Kory, RC. Walking patterns of normal men. Journal of Bone and Joint Surgery 1964;46A:335–60.Google Scholar

Lockhart, TE, Woldstad, JC, Smith, JL. Effects of age-related gait changes on the biomechanics of slips and falls. Ergonomics 2003;46:1136–60.Google Scholar

Kerrigan, DC, Lee, LW, Collins, JJ, et al. Reduced hip extension during walking: Healthy elderly and fallers versus young adults. Arch Phys Med Rehabil 2001;82:26–30.Google Scholar

Lee, LW, Kerrigan, DC. Identification of kinetic differences between fallers and nonfallers in the elderly. Am J Phys Med Rehabil 1999;78:242–6.Google Scholar

Campbell, AJ, Reinken, J, Allan, BC, et al. Falls in old age: a study of frequency and related clinical factors. Age and ageing 1981;10:264–70.Google Scholar

Tinetti, ME, Speechley, M, Ginter, SF. Risk factors for falls among elderly persons living in the community. N Engl J Med 1988;319:1701–7.Google Scholar

Lord, SR, Ward, JA, Williams, P, et al. An epidemiological study of falls in older community-dwelling women: the Randwick falls and fractures study. Aust J Pub Health 1993;17:240–54.Google Scholar

Van Dieen, JH, Pijnappels, M, Bobbert, MF. Age-related intrinsic limitations in preventing a trip and regaining balance after a trip. Safety Science 2005;43:437–53.Google Scholar

Pavol, MJ, Owings, TM, Foley, KT, et al. Gait characteristics as risk factors for falling from trips induced in older adults. J Gerontol 1999;54:M583–90.Google Scholar

Pavol, MJ, Owings, TM, Foley, KT, et al. Mechanisms leading to a fall from an induced trip in healthy older adults. J Gerontol 2001;56:M428–37.Google Scholar

Grabiner, MD, Koh, TJ, Lundin, TM, et al. Kinematics of recovery from a stumble. J Gerontol 1993;48:M97–102.Google Scholar

Cao, C, Ashton-Miller, JA, Schultz, AB, et al. Abilities to turn suddenly while walking: effects of age, gender, and available response time. J Gerontol 1997;52:M88–93.Google Scholar

Lockhart, TE, Smith, JL, Woldstad, JC. Effects of aging on the biomechanics of slips and falls. Hum Factors 2005;47:708–29.Google Scholar

Brady, RA, Pavol, MJ, Owings, TM, et al. Foot displacement but not velocity predicts the outcome of a slip induced in young subjects while walking. J Biomech 2000;33:803–8.Google Scholar

Gillespie, LD, Robertson, MC, Gillespie, WJ, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 2012;9:CD007146.Google Scholar

Sherrington, C, Tiedemann, A, Fairhall, N, et al. Exercise to prevent falls in older adults: an updated meta-analysis and best practice recommendations. NSW Public Health Bull 2011;22:78–83.Google Scholar

Tomlinson, CL, Patel, S, Meek, C, et al. Physiotherapy versus placebo or no intervention in Parkinson’s disease. Cochrane Database Syst Rev 2013. DOI: 10.1002/14651858.CD002817.pub4.Google Scholar

Mehrholz, J, Friis, R, Kugler, J, et al. Treadmill training for patients with Parkinson’s disease. Cochrane Database Syst Rev 2010. DOI: 10.1002/14651858.CD007830.pub2.Google Scholar

English, C, Hillier, SL.Circuit class therapy for improving mobility after stroke. Cochrane Database Syst Rev 2010. DOI: 10.1002/14651858.CD007513.pub2.Google Scholar

Handoll, HHG, Sherrington, C, Mak, JCS. Interventions for improving mobility after hip fracture surgery in adults. Cochrane Database Syst Rev 2011. DOI: 10.1002/14651858.CD001704.pub4.Google Scholar

States, RA, Pappas, E, Salem, Y. Overground physical therapy gait training for chronic stroke patients with mobility deficits. Cochrane Database Syst Rev 2009. DOI: 10.1002/14651858.CD006075.pub2.Google Scholar

Dean, CM, Rissel, C, Sherrington, C, et al. Exercise to enhance mobility and prevent falls after stroke: the Community Stroke Club Randomized Trial. Neurorehabil Neural Repair 2012;26:1046–57.Google Scholar

Binder, EF, Brown, M, Sinacore, DR, et al. Effects of extended outpatient rehabilitation after hip fracture: a randomized controlled trial. JAMA 2004;292:837–46.Google Scholar

Robertson, MC, Campbell, AJ, Gardner, MM, et al. Preventing injuries in older people by preventing falls: a meta-analysis of individual-level data. JAGS 2002;50:905–11.Google Scholar

Campbell, A, Robertson, M, La Grow, S, et al. Randomised controlled trial of prevention of falls in people aged 75 with severe visual impairment: the VIP trial. BMJ 2005;331:817–925.Google Scholar

Fairhall, N, Sherrington, C, Lord, SR, et al. Effect of a multifactorial, interdisciplinary intervention on risk factors for falls and fall rate in frail older people: a randomised controlled trial. Age Ageing 2014;43:616–22.Google Scholar

Sherrington, C, Lord, SR, Vogler, CM, et al. A post-hospital home exercise program improved mobility but increased falls in older people: a randomised controlled trial. PloS one 2014;9:e104412.Google Scholar

Canning, C, Sherrington, C, Lord, S, et al. Exercise for falls prevention in Parkinson’s disease: a randomized controlled trial. Neurology 2015 Jan 20;84(3):304–12.Google Scholar

Bisdorff, A, Von Brevern, M, Lempert, T, Newman-Toker, DE. Classification of vestibular symptoms: towards an international classification of vestibular disorders. J Vestib Res. 2009;19(1–2):1–13.Google Scholar

Newman-Toker, DE, Cannon, LM, Stofferahn, ME, Rothman, RE, Hsieh, YH, Zee, DS. Imprecision in patient reports of dizziness symptom quality: a cross-sectional study conducted in an acute care setting. Mayo Clin Proc. 2007 Nov;82(11):1329–40.Google Scholar

Sloane, PD. Dizziness in primary care: results from the National Ambulatory Medical Care Survey. J Fam Pract. 1989;29(1):33–8.Google Scholar

Kroenke, K, Mangelsdorff, AD. Common symptoms in ambulatory care: incidence, evaluation, therapy, and outcome. Am J Med. 1989;86(3):262–6.Google Scholar

Jonsson, R, Sixt, E, Landahl, S, Rosenhall, U. Prevalence of dizziness and vertigo in an urban elderly population. J Vestib Res. 2004;14(1):47–52.Google Scholar

Wolinsky, FD, Fitzgerald, JF. The risk of hip fracture among noninstitutionalized older adults. J Gerontol. 1994;49(4):165–75.Google Scholar

Wolinsky, FD, Fitzgerald, JF. Subsequent hip fracture among older adults. Am J Public Health. 1994;84(8):1316–18.Google Scholar

Kao, AC, Nanda, A, Williams, CS, Tinetti, ME. Validation of dizziness as a possible geriatric syndrome. J Am Geriatr Soc. 2001;49(1):72–5.Google Scholar

Newman-Toker, DE. Diagnosing Dizziness in the Emergency Department – Why “What do you mean by ‘dizzy’?” Should Not Be the First Question You Ask. [Doctoral Dissertation, Clinical Investigation, Bloomberg School of Public Health] [PhD Clinical Investigation]. Baltimore, MD: The Johns Hopkins University; 2007.Google Scholar

Drachman, DA. A 69-year-old man with chronic dizziness. JAMA. 1998;280(24):2111–8.Google Scholar

Newman-Toker, DE. Symptoms and signs of neuro-otologic disorders. Continuum (Minneap Minn). 2012 Oct;18(5 Neuro-otology):1016–40.Google Scholar

Newman-Toker, DE, Dy, FJ, Stanton, VA, Zee, DS, Calkins, H, Robinson, KA. Primary cardiovascular disease causes true vertigo – a systematic review. Abstracts of the Bárány Society XXV International Congress, Kyoto, Japan, Mar 31–Apr 3, 2008. J Vestib Res. 2008.Google Scholar

Paul, NL, Simoni, M, Rothwell, PM. Transient isolated brainstem symptoms preceding posterior circulation stroke: a population-based study. Lancet Neurology. 2013 Jan;12(1):65–71.Google Scholar

Newman-Toker, DE, Dy, FJ, Stanton, VA, Zee, DS, Calkins, H, Robinson, KA. How often is dizziness from primary cardiovascular disease true vertigo? A systematic review. J Gen Intern Med. 2008 Dec;23(12):2087–94.CrossRefGoogle ScholarPubMed

Fife, TD, Iverson, DJ, Lempert, T, Furman, JM, Baloh, RW, Tusa, RJ, et al. Practice parameter: therapies for benign paroxysmal positional vertigo (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2008;70(22):2067–74.Google Scholar

Lempert, T, Neuhauser, H, Daroff, RB. Vertigo as a symptom of migraine. Annals of the New York Academy of Sciences. 2009 May;1164:242–51.CrossRefGoogle ScholarPubMed

Kattah, JC, Talkad, AV, Wang, DZ, Hsieh, YH, Newman-Toker, DE. HINTS to diagnose stroke in the acute vestibular syndrome: three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging. Stroke. 2009 Nov;40(11):3504–10.Google Scholar

Chalela, JA, Kidwell, CS, Nentwich, LM, Luby, M, Butman, JA, Demchuk, AM, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet. 2007;369(9558):293–8.Google Scholar

Edlow, JA, Newman-Toker, DE, Savitz, SI. Diagnosis and initial management of cerebellar infarction. Lancet Neurol. 2008 Oct;7(10):951–64.Google Scholar

Newman-Toker, DE, Kerber, KA, Hsieh, YH, Pula, JH, Omron, R, Saber Tehrani, AS, et al. HINTS outperforms ABCD2 to screen for stroke in acute continuous vertigo and dizziness. Academic Emergency Medicine: Official Journal of the Society for Academic Emergency Medicine. 2013 Oct;20(10):986–96.Google Scholar

Saber Tehrani, AS, Kattah, JC, Mantokoudis, G, Pula, JH, Nair, D, Blitz, A, et al. Small strokes causing severe vertigo: frequency of false-negative MRIs and nonlacunar mechanisms. Neurology. 2014 Jul 8;83(2):169–73.Google Scholar

Tarnutzer, AA, Berkowitz, AL, Robinson, KA, Hsieh, YH, Newman-Toker, DE. Does my dizzy patient have a stroke? A systematic review of bedside diagnosis in acute vestibular syndrome. CMAJ: Canadian Medical Association Journal [Journal de l’Association medicale canadienne]. [Research Support, Non-US Gov’t Research Support, US Gov’t, PHS Review]. 2011 Jun 14;183(9):E571–92.Google Scholar

Newman-Toker, DE, Saber Tehrani, AS, Mantokoudis, G, Pula, JH, Guede, CI, Kerber, KA, et al. Quantitative video-oculography to help diagnose stroke in acute vertigo and dizziness: toward an ECG for the eyes. Stroke: A Journal of Cerebral Circulation. [Research Support, N.I.H., Extramural Research Support, Non-US Gov’t Research Support, US Gov’t, PHS]. 2013 Apr;44(4):1158–61.Google Scholar

Newman-Toker, DE. Vertigo and dizziness. In: Aminoff, MJ, Daroff, RB, editors. Encyclopedia of the Neurological Sciences. 2nd ed. Oxford: Elsevier; 2014: 629–37.Google Scholar

Parnes, LS, Agrawal, SK, Atlas, J. Diagnosis and management of benign paroxysmal positional vertigo (BPPV). CMAJ. 2003;169(7):681–93.Google Scholar

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.Google Scholar

Alzheimer’s Association. 2014 Alzheimer’s disease facts and figures. Alzheimer’s & Dementia. 2014;1–46.Google Scholar

Elliott, AF, Burgio, LD, Decoster, J. Enhancing caregiver health: findings from the resources for enhancing Alzheimer’s caregiver health II intervention. J Am Geriatr Soc. 2010;58:30–7.Google Scholar

Corrada, MM, Brookmeyer, R, Paganini-Hill, A, et al. Dementia incidence continues to increase with age in the oldest old: the 90+ study. Ann Neurol. 2010; 67:114–21.Google Scholar

Vincent, GK, Velkoff, VA. The next four decades: The older population in the united sates: 2010–2050. Current Population Reports. Washington, DC: US Department of Commerce Economics and Statistics Administration. 2010.Google Scholar

Llewellyn, DJ, Lang, IA, Langa, KM, et al. Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med. 2010;170:1135–41.CrossRefGoogle ScholarPubMed

Norton, MC, Smith, KR, Ostbye, T, et al. Greater risk of dementia when spouse has dementia? The cache county study. J Am Geriatr Soc. 2010;58:895–900.Google Scholar

Fratiglioni, L, Paillard-Borg, S, Winblad, B. An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol. 2004;3:343–53.Google Scholar

Simonsick, EM. Fitness and cognition: encouraging findings and methodological considerations for future work. J Am Geriatr Soc. 2003;51:570–1.Google Scholar

Coyle, JT. Use it or lose it – do effortful mental activities protect against dementia? NEJM. 2003;348:2489–90.Google Scholar

Buchman, AS, Boyle, PA, Yu, L, et al. Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology. 2012;78:1323–9.Google Scholar

Yaffe, K, Fiocco, AJ, Lindquist, K, et al. Predictors of maintaining cognitive function in older adults: the health ABC study. Neurology. 2009;72:2029–35Google Scholar

Jellinger, KA. Morphologic diagnosis of “vascular dementia” – a critical update. Journal of the Neurological Sciences.2008;270: 1–12.Google Scholar

Knopman, DS, Boeve, BF, Petersen, RC. Essential of the proper diagnoses of mild cognitive impairment, dementia, and major subtypes of dementia. Mayo Clin Proc. 2003;78:1290–1308.Google Scholar

Snowden, JS. Semantic dysfunction in frontotemporal lobar degeneration. Dement Geriatr Cogn Disord. 1999;10(Suppl 1):33–6.Google Scholar

Morris, JC. Dementia update 2005. Alzheimer Dis Assoc Disord. 2005;19:100–17.Google Scholar

Jack, CR Jr, Albert, MS, Knopman, DS, et al. Introduction to the recommendations from the national institute on aging – Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:257–62.Google Scholar

Hebert, LE, Weuve, J, Scherr, PA, Evans, DA. Alzheimer disease in the United States (2010–2050) estimated using the 2010 census. Neurology. 2013;80:1778–83.Google Scholar

Barnes, DE, Yaffe, K, Byers, AL, et al. Midlife vs late-life depressive symptoms and risk of dementia: Differential effects for Alzheimer disease and vascular dementia. Arch Gen Psychiatry. 2012;69:493–8.Google Scholar

Querfurth, HW, Laferla, FM. Mechanisms of disease: Alzheimer’s disease. NEJM. 2010;362:1844–5.Google Scholar

Cummings, JL, Vinters, HV, Cole, GM, et al. Alzheimer’s disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology. 1998;51(Suppl 1):S2–S17.Google Scholar

Mash, DC, Flynn, DD, Potter, LT. Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer’s disease and experimental cholinergic degeneration. Science. 1985;228:1115–17.Google Scholar

Cummings, JL. Alzheimer’s disease. NEJM. 2004;351:56–67.Google Scholar

Gandy, S. The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. J Clin Invest. 2005;115(5):1121–9.Google Scholar

Tanzi, RE. Tangles and neurodegenerative disease – a surprising twist. NEJM. 2005;353:1853–5.Google Scholar

Santacruz, K, Lewis, J, Spires, T, et al. Tau suppression in a neuro-degenerative mouse model improves memory function. Science. 2005;309:476–81.Google Scholar

Gorelick, PB, Scuteri, A, Black, SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke. Stroke. 2011;42:2672–713.Google Scholar

Larson, EB, Shadlen, MF, Wang, L, et al. Survival after initial diagnosis of Alzheimer disease. Ann Intern Med. 2004;140:501–9.Google Scholar

Román, GC. Vascular neurocognitive disorder. In: Gabbard’s Treatments of Psychiatric Disorders, 5th ed. Arlington, VA: American Psychiatric Publishing; 2014Google Scholar

Duthie, EH, Glatt, SL. Understanding and treating multi-infarct dementia. Clin Geriatr Med. 1988;4:749–66.Google Scholar

Moorhouse, P, Rockwood, K. Vascular cognitive impairment: current concepts and clinical developments. Lancet Neurol. 2008;7:246–55.Google Scholar

Rincon, F, Wright, CB. Vascular cognitive impairment. Curr Opin Neurol. 2013;26:29–36.Google Scholar

Dichgans, M, Zietemann, V. Prevention of vascular cognitive impairment. Stroke. 2012;43:3137–46.Google Scholar

The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry. 1994;57:416–18.Google Scholar

Whitwell, JL, Jack, CR Jr, Senjem, ML, Josephs, KA. Patterns of atrophy in pathologically confirmed FTLD with and without motor neuron degeneration. Neurology. 2006;66:102–4.Google Scholar

Rabinovici, GD, Miller, BL. Frontotemporal lobar degeneration epidemiology, pathophysiology, diagnosis and management. CNS Drugs. 2010;24:375–98.Google Scholar

McMurtray, AM, Chen, AK, Shapira, JS, et al. Variations in regional SPECT hypoperfusion and clinical features in frontotemporal dementia. Neurology.2006;66:517–22.Google Scholar

Mendez, MF, McMurtray, A, Chen, AK, et al. Functional neuroimaging and presenting psychiatric features in frontotemporal dementia. J Neurol Neurosurg Psychiatry. 2006;77:4–7.Google Scholar

Vanderzee, J, Rademakers, R, Engelborghs, S, et al. A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD. Brain. 2006;129:841–52.Google Scholar

Mackenzie, IR, Baker, M, West, G, et al. A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17. Brain. 2006;129:853–67.Google Scholar

Huey, ED, Putnam, KT, Grafman, J. A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia. Neurology. 2006;66:17–22.Google Scholar

McKhann, GM, Albert, MS, Grossman, M, et al. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick’s Disease. Arch Neurol. 2001;58:1803–9.Google Scholar

Neary, D, Snowden, JS, Northen, B, et al. Dementia of frontal lobe type. J Neurol Neurosurg Psychiatry. 1988;51:353–61.Google Scholar

Chare, L, Hodges, JR, Leyton, CE, et al. New criteria for frontotemporal dementia syndromes: Clinical and pathological diagnostic implications. Journal of Neurology, Neurosurgery & Psychiatry. 2014;85:865–70.Google Scholar

Hodges, JR, Davies, RR, Xuereb, JH, et al. Clinicopathological correlates in frontotemporal dementia. Ann Neurol. 2004;56:399–406.Google Scholar

Eslinger, PJ, Dennis, K, Moore, P, et al. Metacognitive deficits in frontotemporal dementia. J Neurol Neurosurg Psychiatry. 2005;76:1630–5.Google Scholar

Bonner, MF, Ash, S, Grossman, M. The new classification of primary progressive aphasia into semantic, logopenic, or nonfluent/agrammatic variants. Current Neurology & Neuroscience Reports. 2010;10:484–90.Google Scholar

Campbell, S, Stephens, S, Ballard, C. Dementia with Lewy bodies: clinical features and treatment. Drugs Aging. 2001;18:397–407.Google Scholar

McKeith, IG. Spectrum of Parkinson’s disease, Parkinson’s dementia, and Lewy body dementia. Neurol Clin. 2000;18:865–902.Google Scholar

Savica, R, Grossardt, BR, Bower, JH, et al. Incidence of dementia with Lewy bodies and Parkinson disease dementia. JAMA Neurology. 2013;70:1396–402.Google Scholar

Halliday, GM, Song, YJ, Harding, AJ. Striatal beta-amyloid in dementia with Lewy bodies but not parkinson’s disease. J Neural Transm. 2011;118:713–9.Google Scholar

Kalaitzakis, ME, Walls, AJ, Pearce, RK, et al. Striatal abeta peptide deposition mirrors dementia and differentiates DLB and PDD from other parkinsonian syndromes. Neurobiol Dis. 2011;41:377–84.Google Scholar

Kantarci, K, Lowe, VJ, Boeve, BF, et al. Multimodality imaging characteristics of dementia with Lewy bodies. Neurobiol Aging. 2012;33:2091–105.Google Scholar

Klein, JC, Eggers, C, Kalbe, E, et al. Neurotransmitter changes in dementia with Lewy bodies and parkinson disease dementia in vivo. Neurology. 2010;74:885–92.Google Scholar

Shimada, H, Shinotoh, H, Hirano, S, et al. Beta-amyloid in Lewy body disease is related to Alzheimer’s disease-like atrophy. Movement Disorders. 2013;28:169–75.Google Scholar

Kupsch, AR, Bajaj, N, Weiland, F, et al. Impact of DaTscan SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use and safety in patients with clinically uncertain parkinsonian syndromes: A prospective 1-year follow-up of an open-label controlled study. J Neurol Neurosurg Psychiatry. 2012;83:620–8.Google Scholar

Lim, SM, Katsifis, A, Villemagne, VL, et al. The 18 F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies. Journal of Nuclear Medicine. 2009;50:1638–45.Google Scholar

O’Brien, JT, McKeith, IG, Walker, Z, et al. Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies. British Journal of Psychiatry. 2009;194:34–9.Google Scholar

Ferman, TJ, Boeve, BF, Smith, GE, et al. Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies. Neurology. 2011;77:875–82.Google Scholar

Aarsland, D, Andersen, K, Larsen, JP, et al. Risk of dementia in Parkinson’s disease: a community-based, prospective study. Neurology. 2001;56:730–6.Google Scholar

Stern, Y, Marder, K, Tang, MX, Mayeux, R. Antecedent clinical features associated with dementia in Parkinson’s disease. Neurology.1993;43:1690–2.Google Scholar

Emre, M. Dementia in Parkinson’s disease: cause and treatment. Curr Opin Neurol. 2004;17:399–404.Google Scholar

Aarsland, D, Perry, R, Brown, A, et al. Neuropathology of dementia in Parkinson’s disease: a prospective, community-based study. Ann Neurol. 2005;58:773–6.Google Scholar

Quinn, N. Parkinsonism–recognition and differential diagnosis. BMJ. 1995; 310:447–52.Google Scholar

Litvan, I, Campbell, G, Mangone, CA, et al. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. Brain. 1997;120(Pt 1):65–74.Google Scholar

Verny, M, Jellinger, KA, Hauw, JJ, et al. Progressive supranuclear palsy: a clinicopathological study of 21 cases. Acta Neuropathol (Berl). 1996;91:427–31.Google Scholar

Maher, ER, Lees, AJ. The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology. 1986;36:1005–8.Google Scholar

Centers for Disease Control. Creutzfeldt-Jakob disease (CJD). Available at: www.cdc.gov/ncidod/dvrd/cjd (accessed April 28, 2015).Google Scholar

World Health Organization (WHO). WHO manual for surveillance of human transmissible spongiform encephalopathies including variant Creutzfeldt-Jakob disease, 2003. Available at: www.who.int/bloodproducts/TSE-manual2003.pdf (accessed December 2, 2015).Google Scholar

Rinne, ML, McGinnis, SM, Samuels, MA, et al. Clinical problem-solving: a startling decline. N Engl J Med. 2012;366:836–42.Google Scholar

Chohan, G, Pennington, C, Mackenzie, JM, et al. The role of cerebrospinal fluid 14–3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review. Journal of Neurology, Neurosurgery & Psychiatry. 2010;81: 1243–8.Google Scholar

Heath, CA, Cooper, SA, Murray, K, et al. Validation of diagnostic criteria for variant Creutzfeldt-Jakob disease. Ann Neurol. 2010;67:761–70.Google Scholar

Vitali, P, Maccagnano, E, Caverzasi, E, et al. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology. 2011 May;76:1711–19.Google Scholar

Chapman, DP, Williams, SM, Strine, TW, et al. Dementia and its implications for public health. Available at: www.cdc.gov/pcd/issues/2006/apr/05_0167.htm (accessed May 25, 2008).Google Scholar

Wivel, ME. NIMH report: NIH consensus conference stresses need to identify reversible causes of dementia. Hosp Community Psychiatry. 1988;39:22–3.Google Scholar

Clarfield, AM. The decreasing prevalence of reversible dementias: an updated meta-analysis. Arch Intern Med. 2003;163:2219–29.Google Scholar

Clarfield, AM. The reversible dementias: do they reverse? Ann Intern Med. 1988;109:476–86.Google Scholar

Williams, MA, Relkin, NR. Diagnosis and management of idiopathic normal-pressure hydrocephalus. Neurol Clin Pract. 2013;3:375–85.Google Scholar

Kiefer, M, Unterberg, A. The differential diagnosis and treatment of normal-pressure hydrocephalus. Dtsch Arztebl Int. 2012;109:15–25.Google Scholar

Tueth, MJ, Cheong, JA. Delirium: diagnosis and treatment in the older patient. Geriatrics. 1993;48:75–80.Google Scholar

Inouye, SK, Westendorp, RG, Saczynski, JS. Delirium in elderly people. Lancet. 2014;8(383):911–22.Google Scholar

Petersen, RC, Roberts, RO, Knopman, DS, et al. Prevalence of mild cognitive impairment is higher in men: the Mayo Clinic study of aging. Neurology. 2010;75:889–97.Google Scholar

Sachdev, PS, Lipnicki, DM, Crawford, J, et al. Risk profiles of subtypes of mild cognitive impairment: the Sydney memory and ageing study. J Am Geriatr Soc. 2012;60:24–33.Google Scholar

Roberts, RO, Geda, YE, Knopman, DS, et al. The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic study of aging. Neurology. 2012;78:342–51.Google Scholar

Roberts, RO, Geda, YE, Knopman, DS, et al. Cardiac disease associated with increased risk of nonamnestic cognitive impairment: stronger effect on women. JAMA Neurology. 2013;70:374–82.Google Scholar

Mitchell, AJ, Shiri-Feshki, M. Rate of progression of mild cognitive impairment to dementia – meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand. 2009;119:252–65.Google Scholar

Boyle, PA, Buchman, AS, Wilson, RS, et al. The APOE epsilon4 allele is associated with incident mild cognitive impairment among community-dwelling older persons. Neuroepidemiology. 2010;34:43–9.Google Scholar

De Meyer, G, Shapiro, F, Vanderstichele, H, et al. Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. Arch Neurol. 2010;67:949–56.Google Scholar

Heister, D, Brewer, JB, Magda, S, et al. for the Alzheimer’s Disease Neuroimaging Initiative. Predicting MCI outcome with clinically available MRI and CSF biomarkers. Neurology. 2011;77:1619–28.Google Scholar

Landau, SM, Harvey, D, Madison, CM, et al. Comparing predictors of conversion and decline in mild cognitive impairment. Neurology. 2010;75:230–8.Google Scholar

Lo, RY, Hubbard, AE, Shaw, LM, et al. Longitudinal change of biomarkers in cognitive decline. Arch Neurol. 2011;68:1257–66.Google Scholar

Van Rossum, IA, Vos, SJ, Burns, L, et al. Injury markers predict time to dementia in subjects with MCI and amyloid pathology. Neurology. 2012;79:1809–16.Google Scholar

Vemuri, P, Wiste, HJ, Weigand, SD, et al. Serial MRI and CSF biomarkers in normal aging, MCI, and AD. Neurology. 2010;75:143–51.Google Scholar

Small, GW, Rabins, PV, Barry, PP, et al. Diagnosis and treatment of Alzheimer’s disease and related disorders. JAMA. 1997;278:1363–71.Google Scholar

Auer, S, Reisberg, B. The GDS/FAST system. Int Psychogeriatr. 1997;9:167–71.Google Scholar

Folstein, M, Anthony, JC, Parchad, I, et al. The meaning of cognitive impairment in the elderly. J Am Geriatr Soc. 1985;33:228–35.Google Scholar

Hancock, P, Larner, AJ. Test your memory test: diagnostic utility in a memory clinic population. Int J Geriatr Psychiatry. 2011;26:976–80.Google Scholar

Grigoletto, F, Zappala, G, Anderson, DW, et al. Norms for the mini-mental state examination in a healthy population. Neurology. 1999;53:315–20.Google Scholar

Dufouil, C, Clayton, D, Brayne, C, et al. Population norms for the MMSE in the very old: estimates based on longitudinal data. Neurology. 2000;55:1609–13.Google Scholar

Karlawish, JH, Casarett, DJ, James, BD, et al. The ability of persons with Alzheimer disease (AD) to make a decision about taking an AD treatment. Neurology. 2005;64:1514–19.Google Scholar

Pruchno, RA, Smyer, MA, Rose, MS, et al. Competence of long-term care residents to participate in decisions about their medical care: a brief, objective assessment. Gerontologist. 1995;35: 622–9.Google Scholar

Stahelin, HB, Monsch, AU, Spiegel, R. Early diagnosis of dementia via a two-step screening and diagnostic procedure. Int Pyschogeriatr. 1997;9:123–30.Google Scholar

Powlishta, KK, Von Dras, DD, Stanford, A, et al. The clock drawing test is a poor screen for very mild dementia. Neurology. 2002;59:898–903.Google Scholar

Borson, S, Scanlan, J, Brush, M, et al. The Mini-Cog: a cognitive “vital signs” measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry. 2000;15:1021–7.Google Scholar

Borson, S, Scanlan, J, Chen, P, et al. The Mini-Cog as a screen for dementia: validation in a population-based sample. J Am Geriatr Soc. 2003;51:1451–4.Google Scholar

Nasreddine, Z, Phillips, N, Bédirian, V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005; 53:695–9.Google Scholar

Fujiwara, Y, Suzuki, H, Yasunaga, M, et al. Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal Cognitive Assessment. Geriatrics & Gerontology International. 2010;10:225–32.Google Scholar

Larner, AJ. Screening utility of the Montreal Cognitive Assessment (MoCA): in place of – or as well as – the MMSE? International Psychogeriatrics. 2012;24:391–6.Google Scholar

Dong, Y, Sharma, VK, Venketasubramanian, N, et al. The Montreal Cognitive Assessment (MoCA) is superior to the Mini-Mental State Examination (MMSE) for the detection of vascular cognitive impairment after acute stroke. J. Neurol. Sci. 2010;299:15–18.Google Scholar

Godefroy, O, Fickl, A, Roussel, M, et al. Is the Montreal Cognitive Assessment superior to the Mini-Mental State Examination to detect poststroke cognitive impairment? A study with neuropsychological evaluation. Stroke. 2011;42:1712–16.Google Scholar

Pendlebury, ST, Cuthbertson, FC, Welch, SJ, et al. Underestimation of cognitive impairment by Mini-Mental State Examination versus the Montreal Cognitive Assessment in patients with transient ischemic attack and stroke: a population-based study. Stroke. 2010;41:1290–3.Google Scholar

Petersen, RC, Smith, GE, Ivnik, RJ, et al. Apolipoprotein E status as a predictor of the development of Alzheimer’s disease in memory-impaired individuals. JAMA. 1995;273:1274–8.Google Scholar

Chandler, MJ, Lacritz, LH, Hynan, LS, et al. A total score for the CERAD neuropsychological battery. Neurology. 2005;65:102–6.Google Scholar

McGurn, B, Starr, JM, Topfer, JA, et al. Pronunciation of irregular words is preserved in dementia, validating premorbid IQ estimation. Neurology. 2004;62:1184–6Google Scholar

Weyting, MD, Bossuyt, PM, van Crevel, H. Reversible dementia: more than 10% or less than 1%? A quantitative review. J Neurol. 1995;242:466–71.Google Scholar

Mapstone, M, Cheema, AK, Fiandaca, MS, et al. Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med. 2014;20:415–18.Google Scholar

Goldman, JS, Hahn, SE, Catania, JW, et al. Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genet Med. 2011;13:597–605.Google Scholar

Henderson, AS, Easteal, S, Jorm, AF. Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample. Lancet. 1995;346:1387–90.Google Scholar

Galasko, D. Cerebrospinal fluid biomarkers in Alzheimer disease: a fractional improvement? Arch Neurol. 2003;60:1195–6.Google Scholar

Albert, M, DeCarli, C, DeKosky, S, et al. The use of MRI and PET for the clinical diagnosis of dementia and investigation of cognitive impairment: consensus report. Available at: www.alz.org/national/documents/Imaging_consensus_report.pdf (accessed May 25, 2008).Google Scholar

Killiany, RJ, Gomez-Isla, T, Moss, M, et al. Use of structural magnetic resonance imaging to predict who will get Alzheimer’s disease. Ann Neurol. 2000;47:430–9.Google Scholar

Adak, S, Illouz, K, Gorman, W, et al. Predicting the rate of cognitive decline in aging and early Alzheimer disease. Neurology. 2004;63:108–14.Google Scholar

Weiner, MW, Veitch, DP, Aisen, PS, et al. The Alzheimer’s disease neuroimaging initiative: a review of papers published since its inception. Alzheimer’s & Dementia. 2012;8(1 Suppl):S1–68.Google Scholar

Wu, X, Chen, K, Yao, L, et al. Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer’s disease and amnestic mild cognitive impairment. J Neurosci Methods. 2010;192:277–85.Google Scholar

McKhann, GM, Knopman, DS, Chertkow, H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging – Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:263–9.Google Scholar

Klunk, WE, Engler, H, Nordberg, A, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B. Ann Neurol. 2004;55:306–19.Google Scholar

Jack, CR Jr, Lowe, VJ, Weigand, SD, et al. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer’s disease: implications for sequence of pathological events in Alzheimer’s disease. Brain. 2009;132:1355–65.Google Scholar

Cordell, CB, Borson, S, Boustani, M, et al. Alzheimer’s Association recommendations for operationalizing the detection of cognitive impairment during the Medicare annual wellness visit in a primary care setting. Alzheimers Dement. 2013;9:141–50.Google Scholar

Lin, JS, O’Connor, E, Rossom, RC, et al. Screening for cognitive impairment in older adults: a systematic review for the US Preventive Services Task Force. Annals of Internal Medicine. 2013;159(9)601–12.Google Scholar

Trinh, NH, Hoblyn, J, Mohanty, S, et al. Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis. JAMA. 2003;289(2):210–16.Google Scholar

Kaduszkiewicz, H, Zimmermann, T, Beck-Bornhold, HP, et al. Cholinesterase inhibitors for patients with Alzheimer’s disease: systematic review of randomised clinical trials. BMJ. 2005;331:321–7.Google Scholar

Doody, RS, Stevens, JC, Beck, C, et al. Practice parameter: management of dementia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56:1154–66.Google Scholar

Geldmacher, DS, Provenzano, G, McRae, T, et al. Donepezil is associated with delayed nursing home placement in patients with Alzheimer’s disease. J Am Geriatr Soc. 2003;51:937–44.Google Scholar

Grossberg, GT. The ABC of Alzheimer’s disease: behavioral symptoms and their treatment. Int Psychogeriatr. 2002;14(Suppl 1):27–49.Google Scholar

Courtney, C, Farrell, D, Gray, R, et al. Long-term donepezil treatment in 565 patients with Alzheimer’s disease (AD2000): randomized double-blind trial. Lancet. 2004;363:2105–15.Google Scholar

Gill, SS, Anderson, GM, Fischer, HD, et al. Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study. Arch Intern Med. 2009;169:867–73.Google Scholar

Schneider, LS, Dagerman, KS, Higgins, JP, et al. Lack of evidence for the efficacy of memantine in mild Alzheimer disease. Arch Neurol. 2011;68:991–8.Google Scholar

McShane, R, Areosa Sastre, A, Miakaran, N. Memantine for dementia. Cochrane Database Syst Rev. 2006;2:CD003154.Google Scholar

Ridha, BH, Josephs, KA, Rossor, MN. Delusions and hallucinations in dementia with Lewy bodies: worsening with memantine. Neurology. 2005;65:481–2.Google Scholar

Reisberg, B, Doody, R, Stoffler, A, et al. Memantine in moderate-to-severe Alzheimer’s disease. NEJM. 2003;348:1333–41.Google Scholar

Doody, RS, Farlow, M, Aisen, PS, Alzheimer’s Disease Cooperative Study Data Analysis and Publication Committee. Phase 3 trials of solanezumab and bapineuzumab for Alzheimer’s disease. N Engl J Med. 2014;370:1460.Google Scholar

Salloway, S, Sperling, R, Fox, NC, et al. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer’s disease. N Engl J Med. 2014;370:322–33.Google Scholar

Miller, ER, Pastor-Barriuso, R, Dalal, D, et al. Meta-analysis: high dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142:37–46.Google Scholar

Dysken, MW, Sano, M, Asthana, S, et al. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA. 2014;1;311:33–44.Google Scholar

Aisen, PS, Saumier, D, Briand, R, et al. A phase II study targeting amyloid-B with 3-APS in mild-to-moderate Alzheimer disease. Neurology. 2006;67:1757–63.Google Scholar

Scharf, S, Mander, A, Ugoni, A, et al. A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer’s disease. Neurology. 1999;53:197–201.Google Scholar

Rich, JB, Rasmusson, DX, Folstein, MF, et al. Nonsteroidal anti-inflammatory drugs in Alzheimer’s disease. Neurology. 1995;45:51–5.Google Scholar

Coker, LH, Espeland, MA, Hogan, PE, et al. Change in brain and lesion after CEE therapies: the WHIMS-MRI studies. Neurology. 2014;82:427–34.Google Scholar

Coker, LH, Espeland, MA, Rapp, SR, et al. Postmenopausal hormone therapy and cognitive outcomes: the Women’s Health Initiative Memory Study (WHIMS). J Steroid Biochem Mol Biol. 2010;118:304–10.Google Scholar

Birks, J, Grimley, EV, Van Dongen, M. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev. 2002;CD003120.Google Scholar

Snitz, BE, O’Meara, ES, Carlson, MC, et al. Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA. 2009;302:2663–70.Google Scholar

Angell, M, Kassirer, JP. Alternative medicine – the risks of untested and unregulated remedies. NEJM. 1998;339:839–41.Google Scholar

Briones, TL, Darwish, H. Decrease in age-related tau hyperphosphorylation and cognitive improvement following vitamin D supplementation are associated with modulation of brain energy metabolism and redox state. Neuroscience. 2014;262:143–55.Google Scholar

Briones, TL, Darwish, H. Vitamin D mitigates age-related cognitive decline through the modulation of pro-inflammatory state and decrease in amyloid burden. J Neuroinflammation. 2012;9:244.Google Scholar

Craft, S, Baker, LD, Montine, TJ, et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol. 2012;69:29–38.Google Scholar

Newhouse, P, Kellar, K, Aisen, P, et al. Nicotine treatment of mild cognitive impairment: A 6-month double-blind pilot clinical trial. Neurology. 2012;78:91–101.Google Scholar

Salloway, S, Sperling, R, Brashear, HR. Phase 3 trials of solanezumab and bapineuzumab for Alzheimer’s disease. N Engl J Med. 2014;370:1459–60.Google Scholar

Blennow, K, Zetterberg, H, Rinne, JO, et al. AAB-001 201/202 Investigators: effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease. Arch Neurol. 2012;69:1002–10.Google Scholar

Farlow, M, Arnold, SE, van Dyck, CH, et al. Safety and biomarker effects of solanezumab in patients with Alzheimer’s disease. Alzheimer’s & Dementia. 2012;8:261–71.Google Scholar

Dodel, R, Rominger, A, Bartenstein, P, et al. Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer’s disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial. Lancet Neurology. 2013;12:233–43.Google Scholar

Shah, S, Federoff, HJ. Therapeutic potential of vaccines for Alzheimer’s disease. Immunotherapy. 2011;3:287–98.Google Scholar

Wiessner, C, Wiederhold, KH, Tissot, AC, et al. The second-generation active abeta immunotherapy CAD106 reduces amyloid accumulation in APP transgenic mice while minimizing potential side effects. Journal of Neuroscience. 2011;31:9323–31.Google Scholar

Winblad, B, Andreasen, N, Minthon, L, et al. Safety, tolerability, and antibody response of active abeta immunotherapy with CAD106 in patients with alzheimer’s disease: Randomised, double-blind, placebo-controlled, first-in-human study. Lancet Neurology. 2012;11:597–604.Google Scholar

Wilson, RS, Mendes De Leon, CF, Barnes, LL, et al. Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA. 2002;287:742–8.Google Scholar

Wilson, RS, Bennett, DA, Bienias, JL, et al. Cognitive activity and incident AD in a population-based sample of older persons. Neurology. 2002;59:1910–14.Google Scholar

Verghese, J, Lipton, RB, Katz, MJ, et al. Leisure activities and the risk of dementia in the elderly. NEJM. 2003;348:2508–16.Google Scholar

Weuve, J, Kang, JH, Manson, JE, et al. Physical activity, including walking, and cognitive function in older women. JAMA. 2004;292:1454–61.Google Scholar

Van Gelder, BM, Tijhuis, MAR, Kalmijn, S, et al. Physical activity in relation to cognitive decline in elderly men; the FINE study. Neurology. 2004;63:2316–21.Google Scholar

Teri, L, Gibbons, LE, McCurry, SM, et al. Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial. JAMA. 2003;290:2015–22.Google Scholar

Rolland, Y, Rival, L, Pillard, F, et al. Feasibility of regular physical exercise for patients with moderate to severe Alzheimer disease. J Nutr Health Aging. 2000;4:109–13.Google Scholar

Dvorak, RV, Poehlman, ET. Appendicular skeletal muscle mass, physical activity, and cognitive status in patients with Alzheimer’s disease. Neurology. 1998;51:1386–90.Google Scholar

Lauque, S, Arnaud-Battandier, F, Gillette, S, et al. Improvement of weight and fat-free mass with oral nutritional supplementation in patients with Alzheimer’s disease at risk of malnutrition: a prospective randomized study. J Am Geriatr Soc. 2004;52:1702–7.Google Scholar

Scarmeas, N, Luchsinger, JA, Schupf, N, et al. Physical activity, diet, and risk of Alzheimer disease. JAMA. 2009;302:627–37.Google Scholar

Ngandu, T, Lehtisalo, J, Solomon, A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385(9984):2255–63.Google Scholar

Mohamed, S, Rosenheck, R, Lyketsos, CG, et al. Caregiver burden in Alzheimer disease: cross-sectional and longitudinal patient correlates. Am J Geriatr Psychiatry. 2010;18: 917–27.Google Scholar

Okura, T, Langa, KM. Caregiver burden and neuropsychiatric symptoms in older adults with cognitive impairment: the aging, demographics, and memory study (ADAMS). Alzheimer Dis Assoc Disord. 2011;25: 116–21.Google Scholar

Okura, T, Plassman, BL, Steffens, DC, et al. Prevalence of neuropsychiatric symptoms and their association with functional limitations in older adults in the United States: the aging, demographics, and memory study. J Am Geriatr Soc. 2010;58: 330–7.Google Scholar

Brodaty, H, Arasaratnam, C. Meta-analysis of nonpharmacological interventions for neuropsychiatric symptoms of dementia. Am J Psychiatry. 2012;169:946–53.Google Scholar

Teri, L, Rabins, P, Whitehourse, P, et al. Management of behavior disturbance in Alzheimer disease: current knowledge and future directions. Alzheimer Dis Assoc Disord. 1992;6:77–88.Google Scholar

Roca, RP. Managing the behavioral complications of dementia. In: Cobbs, EL, Duthie, EH, Murphy, JB, eds. Geriatric Review Syllabus: A Core Curriculum in Geriatric Medicine. 4th ed., Iowa: Kendall/Hunt; 1999:183–6.Google Scholar

Gitlin, LN, Winter, L, Dennis, MP, Hodgson, N, Hauck, WW. Targeting and managing behavioral symptoms in individuals with dementia: a randomized trial of a nonpharmacological intervention. J Am Geriatr Soc. 2010;58:1465–74.Google Scholar

Lyketsos, CG, Steinberg, M, Tschanz, JT, et al. Mental and behavioral disturbances in dementia. Am J Psychiatry. 2000;157:708–14.Google Scholar

Khachiyants, N, Trinkle, D, Son, SJ, et al. Sundown syndrome in persons with dementia: an update. Psychiatry Investig. 2011;4:275–87.Google Scholar

Cohen-Mansfield, J, Werner, P. Management of verbally disruptive behaviors in nursing home residents. J Gerontol Med Sci. 1996;52:M369–77.Google Scholar

Sloane, PD, Hoeffer, B, Mitchell, CM, et al. Effect of person-centered showering and the towel bath on bathing-associated aggression, agitation, and discomfort in nursing home residents with dementia: a randomized, controlled trial. J Am Geriatr Soc. 2004;52:1795–1804.Google Scholar

Porsteinsson, AP, Drye, LT, Pollock, BG, et al. Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. JAMA. 2014;311:682–91.Google Scholar

Lonergan, E, Luxenberg, J, Colford, J. Haloperidol for agitation in dementia. Cochrane Database Syst Rev. 2002;CD0003154.Google Scholar

Wilson, MP, Pepper, D, Currier, GW, et al. The psychopharmacology of agitation: consensus statement of the American Association for Emergency Psychiatry Project Beta psychopharmacology workgroup. West J Emerg Med. 2012;13:26–34.Google Scholar